Structure Therapeutics (GPCR) Net Cash Flow (2022 - 2026)
Quarterly Net Cash Flow fell 2680.55% to -$483.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $164.0 million through Mar 2026, up 202.16% year-over-year, with the annual reading at $630.1 million for FY2025, 1486.47% up from the prior year.
Structure Therapeutics' Net Cash Flow history spans 5 years, with the latest figure at -$483.5 million for Q1 2026.
- Net Cash Flow came in at -$483.5 million for Q1 2026, down from $696.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $696.7 million in Q4 2025 to a low of -$483.5 million in Q1 2026.
- The 5-year median for Net Cash Flow is -$5.1 million (2025), against an average of $12.4 million.
- Year-over-year, Net Cash Flow skyrocketed 26692.02% in 2025 and then plummeted 2680.55% in 2026.
- Structure Therapeutics' Net Cash Flow stood at -$2.0 million in 2022, then skyrocketed by 4055.82% to $79.2 million in 2023, then plummeted by 103.31% to -$2.6 million in 2024, then surged by 26692.02% to $696.7 million in 2025, then plummeted by 169.39% to -$483.5 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Net Cash Flow are -$483.5 million (Q1 2026), $696.7 million (Q4 2025), and -$44.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -152.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -483.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -483.46 Mn |
| Mar 31, 2026 | -483.46 Mn |
| Dec 31, 2025 | 696.71 Mn |
| Dec 31, 2025 | 696.71 Mn |
| Sep 30, 2025 | -44.11 Mn |
| Sep 30, 2025 | -44.11 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -5.10 Mn |
| Mar 31, 2025 | -17.39 Mn |
| Mar 31, 2025 | -17.39 Mn |
| Dec 31, 2024 | -2.62 Mn |
| Dec 31, 2024 | -2.62 Mn |
| Sep 30, 2024 | -209.50 Mn |
| Sep 30, 2024 | -209.50 Mn |
| Jun 30, 2024 | 283.80 Mn |
| Jun 30, 2024 | 283.80 Mn |
| Mar 31, 2024 | -31.96 Mn |
| Mar 31, 2024 | -31.96 Mn |
| Dec 31, 2023 | 79.16 Mn |
| Dec 31, 2023 | 79.16 Mn |
| Sep 30, 2023 | 10.05 Mn |
| Sep 30, 2023 | 10.05 Mn |
| Jun 30, 2023 | -85.90 Mn |
| Jun 30, 2023 | -85.90 Mn |
| Mar 31, 2023 | 100.40 Mn |
| Mar 31, 2023 | 100.40 Mn |
| Dec 31, 2022 | -2.00 Mn |
| Dec 31, 2022 | -2.00 Mn |
| Sep 30, 2022 | -27.40 Mn |
| Sep 30, 2022 | -27.40 Mn |
| Jun 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 4.87 Mn |
| Mar 31, 2022 | -54.68 Mn |
| Mar 31, 2022 | -54.68 Mn |